Consolidated Statements of Operations (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Consolidated Statements of Operations
Gross sales	$ 24,586,118	$ 20,575,794	$ 51,257,039	$ 24,843,804
Program costs and discounts	(5,220,414)	(5,327,012)	(10,196,353)	(6,358,982)
Net sales	19,365,704	15,248,782	41,060,686	18,484,822
Costs of sales	5,862,635	7,756,963	13,878,643	9,153,149
Gross profit	13,503,069	7,491,819	27,182,043	9,331,673
Commissions and incentives	6,004,515	2,689,836	12,978,029	3,203,947
Gain on sale of assets	(140,985)		(406,912)
Selling, general and administrative	11,745,831	8,140,390	21,455,360	10,454,806
Operating loss	(4,106,292)	(3,338,407)	(6,844,434)	(4,327,080)
Loss on marketable securities	58,289		552,085
Interest expense, net	213,459	367,052	479,378	604,048
Loss before income tax provision	(4,378,040)	(3,705,459)	(7,875,897)	(4,931,128)
Income tax provision	212,921		491,921
Net loss	(4,590,961)	(3,705,459)	(8,367,818)	(4,931,128)
Net loss attributable to noncontrolling interest	(1,046,175)	(808,117)	(1,686,020)	(784,672)
Net loss attributed to CVSL stockholders	$ (3,544,786)	$ (2,897,342)	$ (6,681,798)	$ (4,146,456)
Basic and diluted loss per share:
Weighted average common shares outstanding (in shares)	992,831,373	992,525,840	992,882,941	992,525,840
Net loss per share attributable to CVSL stockholders (in dollars per share)	$ 0.00	$ 0.00	$ 0.01	$ 0.00